JP2023502738A5 - - Google Patents
Info
- Publication number
- JP2023502738A5 JP2023502738A5 JP2022529813A JP2022529813A JP2023502738A5 JP 2023502738 A5 JP2023502738 A5 JP 2023502738A5 JP 2022529813 A JP2022529813 A JP 2022529813A JP 2022529813 A JP2022529813 A JP 2022529813A JP 2023502738 A5 JP2023502738 A5 JP 2023502738A5
- Authority
- JP
- Japan
- Prior art keywords
- tablet according
- months
- orally disintegrating
- disintegration
- zonisamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19383034 | 2019-11-22 | ||
| EP19383034.6 | 2019-11-22 | ||
| PCT/EP2020/082809 WO2021099531A1 (en) | 2019-11-22 | 2020-11-20 | Zonisamide orodispersible tablets |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502738A JP2023502738A (ja) | 2023-01-25 |
| JP2023502738A5 true JP2023502738A5 (https=) | 2023-11-08 |
| JP7650274B2 JP7650274B2 (ja) | 2025-03-24 |
Family
ID=68808236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529813A Active JP7650274B2 (ja) | 2019-11-22 | 2020-11-20 | ゾニサミド口腔分散性錠剤 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4061328B1 (https=) |
| JP (1) | JP7650274B2 (https=) |
| ES (1) | ES2976470T3 (https=) |
| PT (1) | PT4061328T (https=) |
| WO (1) | WO2021099531A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024090218A (ja) * | 2022-12-22 | 2024-07-04 | ダイト株式会社 | 崩壊遅延を改善したゾニサミド含有口腔内速崩壊錠 |
| AU2024227385A1 (en) * | 2024-03-28 | 2025-10-16 | Athena Pharmaceutiques Sas | Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2393640T3 (es) * | 2008-02-13 | 2012-12-26 | Dainippon Sumitomo Pharma Co., Ltd. | Comprimidos bucodisgregables |
| JP5680898B2 (ja) * | 2010-08-10 | 2015-03-04 | 京都薬品工業株式会社 | 苦味を抑制した速崩壊錠 |
| JP6230539B2 (ja) | 2012-09-20 | 2017-11-15 | 株式会社ダイセル | 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤 |
| JP6271802B1 (ja) * | 2017-09-28 | 2018-01-31 | 武田テバファーマ株式会社 | 口腔内崩壊錠 |
-
2020
- 2020-11-20 WO PCT/EP2020/082809 patent/WO2021099531A1/en not_active Ceased
- 2020-11-20 JP JP2022529813A patent/JP7650274B2/ja active Active
- 2020-11-20 ES ES20808117T patent/ES2976470T3/es active Active
- 2020-11-20 EP EP20808117.4A patent/EP4061328B1/en active Active
- 2020-11-20 PT PT208081174T patent/PT4061328T/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6162196B2 (ja) | 遅延性持続ドラッグデリバリー | |
| AU2005319367B2 (en) | Pharmaceutical compositions for sleep disorders | |
| JP5183470B2 (ja) | レベチラセタムを含む薬剤組成物及びその調製方法 | |
| JP2015091822A5 (https=) | ||
| JP2011500583A5 (https=) | ||
| CN102341099A (zh) | R-巴氯芬前药的持续释放口服剂型 | |
| SG173044A1 (en) | Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same | |
| CN102170870A (zh) | 恩他卡朋或其盐的缓释药物组合物 | |
| TWI491395B (zh) | 一種內含用以治療神經退化性疾病之立即釋出與長效釋出藥物的口服劑量配方 | |
| JP2023502738A5 (https=) | ||
| HUE031251T2 (en) | Controlled release oral dosage form containing oxycodone | |
| CA3104695A1 (en) | Formulations of ag10 | |
| JP2019142834A (ja) | プレガバリン並びに好適な賦形剤を含有する固形製剤 | |
| WO2013100630A1 (en) | Fixed dose combination formulation comprising losartan, amlodipine and hydrochlorothiazide | |
| WO2012070785A1 (en) | Sustained-release pharmaceutical composition comprising levetiracetam or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same | |
| WO2020005189A2 (en) | Solid oral pharmaceutical compositions comprising teriflunomide | |
| JP2019052147A (ja) | 化学的な安定性が改善された、プレガバリン含有口腔内崩壊錠 | |
| WO2021095779A1 (ja) | 口腔内崩壊錠 | |
| EP2875807B1 (en) | Tablet formulation of colesevelam | |
| JP2025535941A5 (https=) | ||
| AU2012241407B2 (en) | Modified release pharmaceutical compositions of Desvenlafaxine | |
| JP2017014151A (ja) | 光安定性を向上した、シロドシンを含有する有核錠 | |
| WO2013180675A1 (en) | Tablet formulation comprising dapoxetine | |
| JP2018118909A (ja) | プレガバリン含有医薬組成物 | |
| RU2007142557A (ru) | Матричная таблетка с основой для пролонгированного высвобождения триметазидина дигидрохлорида, способ ее получения и способ лечения |